Trials / Completed
CompletedNCT01733368
QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead
Observational Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 198 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Optimization and evolution of the patient will be evaluated over 6 months after the implant.
Detailed description
Patient will be enrolled into the study after Informed Consent signature and CRT-D+quadripolar (QuartetTM) LV lead.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-08-01
- Completion
- 2016-08-01
- First posted
- 2012-11-27
- Last updated
- 2019-02-04
- Results posted
- 2018-03-01
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01733368. Inclusion in this directory is not an endorsement.